LACK OF PHARMACOKINETIC INTERACTION BETWEEN VINPOCETINE AND OXAZEPAM

被引:2
作者
STORM, G
OOSTERHUIS, B
SOLLIE, FAE
VISSCHER, HW
SOMMER, W
BEITINGER, H
JONKMAN, JHG
机构
[1] PHARMA BIORES INT BV,9400 AE ZUIDLAREN,NETHERLANDS
[2] THIEMANN ARZNEIMITTEL GMBH,WALTROP,GERMANY
关键词
OXAZEPAM; VINPOCETINE; INTERACTION; PLASMA PROTEIN BINDING; DIURNAL VARIATION;
D O I
10.1111/j.1365-2125.1994.tb04338.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of multiple doses of vinpocetine (10 mg three times daily) on the steady state plasma concentrations of oxazepam (10 mg three times daily) was studied in 16 healthy subjects. The mean (+/- s.d.) AUC (ng ml(-1) h(-1)) of oxazepam over 24 h during combined treatment was 4716 +/- 2296 and for oxazepam treatment alone it was 4737 +/- 2448 (95% confidence intervals for ratio of means = 95.4-103.7%). The degree of plasma protein binding of oxazepam was 98.11 +/- 0.32% and was not affected by vinpocetine. Independent of vinpocetine treatment a significant diurnal change in the plasma binding of oxazepam was observed; the free drug fraction was 20% higher during the night than during the day. C-max and AUC values based on total oxazepam in plasma were 10% lower during the night. The results indicate a lack of influence of vinpocetine on oxazepam kinetics. Diurnal changes in the plasma binding of oxazepam probably have no clinical consequences.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
[21]   Pharmacokinetic interaction between efavirenz and rifampicin in healthy volunteers [J].
Yenny ;
Nafrialdi ;
Djoerban, Z. ;
Setiabudy, R. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) :162-168
[22]   Pharmacokinetic Interaction Study between Imatinib with Sorafenib in Rats [J].
Wang, Shuanghu ;
Zhou, Yunfang ;
Geng, Peiwu ;
Zhang, Qingwei ;
Wen, Congcong .
LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (10) :1723-1727
[23]   Case report: Pharmacokinetic interaction between clozapine and mirtazapine [J].
Lo Presti, C. ;
Laguin, S. ;
Bambina, E. ;
Arlotto, E. ;
Aghazarian, V. ;
Guise-Honore, S. .
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2019, 45 (04) :363-364
[24]   Prolonged pharmacokinetic drug interaction between terbinafine and amitriptyline [J].
Castberg, Ingrid ;
Helle, Jon ;
Aamo, Trond O. .
THERAPEUTIC DRUG MONITORING, 2005, 27 (05) :680-682
[25]   Lack of interaction between thioctic acid, glibenclamide and acarbose [J].
Gleiter, CH ;
Schreeb, KH ;
Freudenthaler, S ;
Thomas, M ;
Elze, M ;
Fieger-Büschges, H ;
Potthast, H ;
Schneider, E ;
Schug, BS ;
Blume, HH ;
Hermann, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (06) :819-825
[26]   Lack of interaction between meloxicam and warfarin in healthy volunteers [J].
Turck, D ;
Su, CAPF ;
Heinzel, G ;
Busch, U ;
Bluhmki, E ;
Hoffmann, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 51 (05) :421-425
[27]   Lack of interaction between meloxicam and warfarin in healthy volunteers [J].
D. Türck ;
C. A. P. F. Su ;
G. Heinzel ;
U. Busch ;
E. Bluhmki ;
J. Hoffmann .
European Journal of Clinical Pharmacology, 1997, 51 :421-425
[28]   Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression [J].
Szymura-Oleksiak, J ;
Wyska, E ;
Wasieczko, A .
PSYCHOPHARMACOLOGY, 2001, 154 (01) :38-42
[29]   Reversed phase liquid chromatographic determination of vinpocetine in human plasma and its pharmacokinetic application [J].
Abd Elbary, A ;
Foda, N ;
El-Gazayerly, O ;
El Khatib, M .
ANALYTICAL LETTERS, 2002, 35 (06) :1041-1054
[30]   Pharmacokinetic interaction between high-dose methotrexate and oxacillin [J].
Titier, K ;
Lagrange, F ;
Péhourcq, F ;
Moore, N ;
Molimard, M .
THERAPEUTIC DRUG MONITORING, 2002, 24 (04) :570-572